JP6976937B2 - 酵素的方法によって人参のサポニンからジンセノサイドF2、コンパウンドMcおよびコンパウンドOを選択的に製造する方法 - Google Patents
酵素的方法によって人参のサポニンからジンセノサイドF2、コンパウンドMcおよびコンパウンドOを選択的に製造する方法 Download PDFInfo
- Publication number
- JP6976937B2 JP6976937B2 JP2018519910A JP2018519910A JP6976937B2 JP 6976937 B2 JP6976937 B2 JP 6976937B2 JP 2018519910 A JP2018519910 A JP 2018519910A JP 2018519910 A JP2018519910 A JP 2018519910A JP 6976937 B2 JP6976937 B2 JP 6976937B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- ginsenoside
- enzyme
- reaction
- ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229930182490 saponin Natural products 0.000 title claims description 47
- 150000007949 saponins Chemical class 0.000 title claims description 45
- 241000208340 Araliaceae Species 0.000 title claims description 44
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims description 44
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims description 44
- 235000008434 ginseng Nutrition 0.000 title claims description 44
- 239000001397 quillaja saponaria molina bark Substances 0.000 title claims description 38
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 title claims description 20
- CJFGBCWGOQRURQ-UHFFFAOYSA-N ginsenoside Mc Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CJFGBCWGOQRURQ-UHFFFAOYSA-N 0.000 title claims description 16
- SWIROVJVGRGSPO-UHFFFAOYSA-N Ginsenoside F2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O SWIROVJVGRGSPO-UHFFFAOYSA-N 0.000 title claims description 15
- AVTXSAWPGCSYFO-UHFFFAOYSA-N Ginsenoside Ia Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O AVTXSAWPGCSYFO-UHFFFAOYSA-N 0.000 title claims description 15
- SWIROVJVGRGSPO-JBVRGBGGSA-N ginsenoside F2 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SWIROVJVGRGSPO-JBVRGBGGSA-N 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 14
- 238000006911 enzymatic reaction Methods 0.000 title description 5
- 108090000790 Enzymes Proteins 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 24
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 12
- 241000228212 Aspergillus Species 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000003125 aqueous solvent Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 108010059820 Polygalacturonase Proteins 0.000 claims description 7
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 claims description 6
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical group C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 claims description 5
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 claims description 5
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 claims description 5
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 claims description 5
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 claims description 4
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 claims description 4
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 claims description 4
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 3
- 235000017709 saponins Nutrition 0.000 description 43
- 229940088598 enzyme Drugs 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229930182494 ginsenoside Natural products 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 101710130006 Beta-glucanase Proteins 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- PVLHOJXLNBFHDX-XHJPDDKBSA-N Panaxadiol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(CC[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 PVLHOJXLNBFHDX-XHJPDDKBSA-N 0.000 description 3
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 241000459887 Aspergillus luchuensis Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- YIYRCZFIJNGYOG-QINBLQPGSA-N gypenoside LXXV Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YIYRCZFIJNGYOG-QINBLQPGSA-N 0.000 description 1
- ZRBFCAALKKNCJG-SJYBZOGZSA-N gypenoside XVII Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZRBFCAALKKNCJG-SJYBZOGZSA-N 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 108010001078 naringinase Proteins 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- -1 saponin saponin Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/12—Acting on D ring
- C12P33/16—Acting at 17 position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01015—Polygalacturonase (3.2.1.15)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Description
紅参、白参、水参、尾参あるいはこれらの人参の葉、人参の花、人参の実2kgにエタノール20リットル(L)を入れ、3回還流抽出した後、15℃で6日間沈積させた。その後、ろ過布ろ過と遠心分離を通じて残渣とろ液を分離し、分離されたろ液を減圧濃縮して得られたエキスを水に懸濁した後に、エーテル1Lで5回抽出して色素を除去し、水層を1‐ブタノール1Lで3回抽出した。これから得られた総1‐ブタノール層を5%KOHで処理した後に、蒸留水で洗浄し、減圧濃縮して1‐ブタノールエキスを収得し、これを少量のメタノールに溶かした後、大量の酢酸エチルに加えて、生成された沈殿物を乾燥させることによって、人参精製サポニン(ジンセノサイドRb1、Rb2、Rc、Rd、Re、Rg1、Rfなどを含む)40〜80gを収得した。
上記参考例1の人参精製サポニン(ジンセノサイドRb1、Rb2、Rc、Rd、Re、Rg1、Rfなどを含む)10gを水1Lに入れて溶解した。
その後、上記混合液にアスペルギルスアクレアタスから分離したペクチナーゼを基質対比200重量%添加した後、30℃で24時間反応させた。薄層クロマトグラフィーによって周期的に確認して基質が完全に消失されると、沸騰水浴槽で10分間加熱して酵素を不活性化させて、反応を終了させた。最後に、反応液に酢酸エチルを1:1の比率(反応液に対する体積比)で入れて、3回抽出した後に濃縮し、シリカゲルカラムクロマトグラフィー(クロロホルム:メタノール=9:1)によって、図1に示すようにジンセノサイドF2、コンパウンドMc、コンパウンドOを分離した。
Claims (5)
- アスペルギルスアクレアタスから分離したペクチナーゼを用いて、人参のサポニンを転換させることによって、下記の化学式1で示すジンセノサイドF2、下記の化学式2で示すコンパウンドMcまたは下記の化学式3で示すコンパウンドOを選択的に製造する方法であって、
[化学式1]
(2)前記の基質が完全消失したら、酵素を不活性化させて反応を終了させる段階と、
(3)前記段階(2)で得た反応液に酢酸エチルを添加して抽出した後に濃縮させて、ジンセノサイドF2、コンパウンドMcまたはコンパウンドOを分離する段階と、
を含む方法。 - 前記(1)の酵素の反応は、基質の量に対して200重量%の量で用いられることを特徴とする請求項1に記載の方法。
- 前記(1)の酵素の反応は、30℃の温度で行われることを特徴とする請求項1に記載の方法。
- 前記(1)の酵素の反応は、24時間行われることを特徴とする請求項1に記載の方法。
- 前記の水性溶媒または水性溶媒と有機溶媒との混合液は、pHが3.5〜5.5の範囲であることを特徴とする請求項1に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2015-0147353 | 2015-10-22 | ||
KR1020150147353A KR20170047007A (ko) | 2015-10-22 | 2015-10-22 | 효소적 방법에 의하여 인삼의 사포닌으로부터 진세노사이드 F2, 컴파운드 Mc 및 컴파운드 O를 선택적으로 제조하는 방법 |
PCT/KR2016/011900 WO2017069561A1 (ko) | 2015-10-22 | 2016-10-21 | 효소적 방법에 의하여 인삼의 사포닌으로부터 진세노사이드 f2, 컴파운드 mc 및 컴파운드 o를 선택적으로 제조하는 방법 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018531018A JP2018531018A (ja) | 2018-10-25 |
JP2018531018A6 JP2018531018A6 (ja) | 2018-12-13 |
JP6976937B2 true JP6976937B2 (ja) | 2021-12-08 |
Family
ID=58557402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018519910A Active JP6976937B2 (ja) | 2015-10-22 | 2016-10-21 | 酵素的方法によって人参のサポニンからジンセノサイドF2、コンパウンドMcおよびコンパウンドOを選択的に製造する方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US10526632B2 (ja) |
EP (1) | EP3351638A4 (ja) |
JP (1) | JP6976937B2 (ja) |
KR (1) | KR20170047007A (ja) |
CN (1) | CN108138211B (ja) |
TW (1) | TWI723055B (ja) |
WO (1) | WO2017069561A1 (ja) |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0178863B1 (ko) * | 1996-11-29 | 1999-04-01 | 김진하 | 인삼 사포닌 대사 생산물의 제조법 |
CN1105781C (zh) * | 1999-03-17 | 2003-04-16 | 金凤燮 | 酶法改变人参皂甙糖基制备人参皂甙的方法 |
US7044985B2 (en) * | 1999-12-21 | 2006-05-16 | Clariant Finance (Bvi) Limited | Process for pre-treating cellulosic fibers and cellulosic fiber blends |
KR100403570B1 (ko) | 2000-12-29 | 2003-10-30 | 주식회사 케이티앤지 | 효소적 방법에 의한 진세노사이드 f₂의 제조방법 |
KR100868905B1 (ko) * | 2004-03-26 | 2008-11-14 | (주)아모레퍼시픽 | 진세노사이드 f1과 egcg을 함유한 자외선 조사로유도되는 피부손상 방지용 조성물 |
KR20090061107A (ko) * | 2007-12-11 | 2009-06-16 | 메타볼랩(주) | 진세노사이드 f2로의 전환방법 |
CN101565694B (zh) * | 2008-04-25 | 2014-12-24 | 天士力制药集团股份有限公司 | 丹酚酸酶及丹酚酸酶和人参皂苷混合酶的制备方法及用所制得的酶转化药材的方法 |
KR101079293B1 (ko) * | 2009-03-27 | 2011-11-04 | 건국대학교 산학협력단 | 고온성 베타-글리코시다아제를 이용한 희귀 진세노사이드의제조방법 |
EP2432891B1 (en) * | 2009-05-19 | 2018-04-04 | Il Hwa Co., Ltd. | Methods for preparing a fermented ginseng concentrate or powder |
KR101098027B1 (ko) * | 2009-09-18 | 2011-12-27 | 한국과학기술원 | 로다노박터 진세노시디뮤탄스 kctc22231t 유래의 진세노시드 글리코시다제 및 이의 용도 |
KR101753077B1 (ko) | 2010-05-07 | 2017-07-03 | 에스케이바이오랜드 주식회사 | 발효 인삼추출물의 제조방법 및 이를 함유하는 조성물 |
WO2012070724A1 (ko) * | 2010-11-24 | 2012-05-31 | 한국생명공학연구원 | 로다노박터 진세노시디뮤탄스 유래의 알파-n-아라비노퓨라노시다제 및 이의 용도 |
CN102094052B (zh) * | 2010-12-12 | 2013-04-17 | 大连理工大学 | 一种糖苷酶催化与盐析萃取偶联制备天然药物的方法 |
KR101514775B1 (ko) * | 2011-04-29 | 2015-06-05 | 한국생명공학연구원 | 유산균 유래의 글리코시드 히드롤라제 및 이의 용도 |
WO2012148249A2 (ko) * | 2011-04-29 | 2012-11-01 | 한국생명공학연구원 | 유산균 유래의 글리코시드 히드롤라제 및 이의 용도 |
KR101823585B1 (ko) * | 2011-07-01 | 2018-01-31 | 에스케이바이오랜드 주식회사 | 발효 인삼추출물의 제조방법 |
US9056112B2 (en) * | 2011-12-28 | 2015-06-16 | Dr. Reddy's Laboratories Limited | Process for preparation of pure linagliptin |
KR101408985B1 (ko) * | 2012-06-20 | 2014-06-17 | 건국대학교 산학협력단 | 페니실리움 아큘레툼 유래 베타-글루코시다아제를 이용한 다양한 희귀 진세노사이드 제조방법 |
CN104762280B (zh) * | 2015-01-25 | 2017-11-10 | 东北师范大学 | 一种重组糖苷水解酶用于生物转化制备人参二醇型皂苷的工艺 |
CN104894204B (zh) * | 2015-05-27 | 2018-04-17 | 金凤燮 | 微生物酶转化人参茎叶皂苷制备人参稀有皂苷的方法 |
-
2015
- 2015-10-22 KR KR1020150147353A patent/KR20170047007A/ko not_active Application Discontinuation
-
2016
- 2016-10-21 CN CN201680062008.8A patent/CN108138211B/zh active Active
- 2016-10-21 TW TW105134029A patent/TWI723055B/zh active
- 2016-10-21 WO PCT/KR2016/011900 patent/WO2017069561A1/ko active Application Filing
- 2016-10-21 EP EP16857818.5A patent/EP3351638A4/en active Pending
- 2016-10-21 US US15/769,964 patent/US10526632B2/en active Active
- 2016-10-21 JP JP2018519910A patent/JP6976937B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
TW201718867A (zh) | 2017-06-01 |
US20180305726A1 (en) | 2018-10-25 |
JP2018531018A (ja) | 2018-10-25 |
CN108138211B (zh) | 2021-08-10 |
KR20170047007A (ko) | 2017-05-04 |
EP3351638A1 (en) | 2018-07-25 |
TWI723055B (zh) | 2021-04-01 |
EP3351638A4 (en) | 2019-05-15 |
CN108138211A (zh) | 2018-06-08 |
US10526632B2 (en) | 2020-01-07 |
WO2017069561A1 (ko) | 2017-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6854815B2 (ja) | 酵素的方法によって人参のサポニンからジンセノサイドRdを選択的に製造する方法 | |
KR20230157273A (ko) | 효소적 방법에 의하여 인삼의 사포닌으로부터 컴파운드 k 및 컴파운드 y를 선택적으로 제조하는 방법 | |
JP2018531029A6 (ja) | 酵素的方法によって人参のサポニンからジンセノサイドRdを選択的に製造する方法 | |
JP6976937B2 (ja) | 酵素的方法によって人参のサポニンからジンセノサイドF2、コンパウンドMcおよびコンパウンドOを選択的に製造する方法 | |
KR20180013526A (ko) | 진세노사이드 Rh1의 제조방법 | |
JP2018531018A6 (ja) | 酵素的方法によって人参のサポニンからジンセノサイドF2、コンパウンドMcおよびコンパウンドOを選択的に製造する方法 | |
CN102071232A (zh) | 一种固定化酶法合成茶黄素的方法 | |
CN107119085A (zh) | 一种基于黑曲霉细胞催化柚皮苷水解制备柚皮素的方法 | |
KR100689745B1 (ko) | 알파-갈락토시다제를 이용하는 진세노사이드 제조방법 | |
KR101315942B1 (ko) | 아스트라갈린의 제조 방법 | |
CN110559347A (zh) | 牡丹花粉黄酮类物质的提取纯化方法 | |
CN109022530B (zh) | 一种人参皂苷Ro的制备方法 | |
KR100318304B1 (ko) | 진세노사이드알지1의제조방법 | |
CN116854761A (zh) | 一种稀有人参皂苷五联体及其制备方法 | |
KR20050077140A (ko) | 베타갈락토시다제를 이용하여 진세노사이드 f1을제조하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190927 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200915 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201215 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210525 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210819 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211102 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211110 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6976937 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |